Reuters

Biocon extends research partnership with Cuba's CMI

MUMBAI, Sept 27 (Reuters) - Biocon Ltd said on Monday it had strengthened its existing research partnership with Cuba-based Center of Molecular Immunology (CMI) to create a product pipeline focused on ...
Nature

Biocon Bristol-Myers Squibb Research and Development Center (BBRC)

Biocon Bristol-Myers Squibb Research and Development Center (BBRC) has the following research output in the current window (1 November 2024 - 31 October 2025) of the Nature Index. Click on Count to ...
AOL

India's Biocon developing its own version of Wegovy, clinical trial likely next year

HYDERABAD (Reuters) - Indian drugmaker Biocon, looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of Novo Nordisk's wildly popular ...
Reuters

Biocon sees growth on research services, insulin

BANGALORE, April 19 (Reuters) - India's largest biotechnology firm, Biocon Ltd. , sees strong growth in the current fiscal year on new drug discovery and large research outsourcing services contracts, ...
Morningstar

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon ...
Morningstar

Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options

BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...
JD Supra

Biosimilar Deals Updates: Biocon, AstraZeneca

As an update to our previous report, Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) announced the successful completion of the transition of the acquired biosimilars business in approximately 120 ...
MarketWatch

India's Biocon enters research tie-up with Bristol-Myers Squibb

MUMBAI (MarketWatch) -- Biocon Ltd. (532523.BY), an Indian biotechnology company, Wednesday said that its unit, Syngene International Pvt. Ltd., has entered into a research tie-up with U.S.-based ...
GEN

Biocon Biologics Receives EU Good Manufacturing Practice Certification

Biocon Biologics, a subsidiary of Biocon, received a European Union GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug ...
Nasdaq

India's Biocon names Peter Bains as group CEO

BENGALURU, Sept 18 (Reuters) - Indian drugmaker Biocon Ltd BION.NS on Monday appointed Peter Bains as the group's chief executive officer, effective immediately. Bains, who was named as an independent ...
Nature

Biocon Bristol-Myers Squibb Research and Development Center (BBRC)

Article ‘Count’ and ‘Share’ for Biocon Bristol-Myers Squibb Research and Development Center (BBRC) based on listed parameters only. The articles listed below published by authors from Biocon ...